GlassScriptPhysician profile
James R Ramsey
NPI 1376531582
$5,937.93
in general payments reported to CMS, 2019-2025
16 companies · $453 in 2025
The $453 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,667 · 2020: $2,623 · 2021: $59.85 · 2022: $447 · 2023: $302 · 2024: $385 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,140.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $2,845.53 | 2019-2025 | |
| Arthrex, INC. | $1,671.09 | 2019-2020 | |
| Zynex Medical, INC. | $326.95 | 2023-2025 | Nexwave |
| Encore Medical, LP | $178.22 | 2019-2024 | Djo Surgical |
| Advita Ortho, LLC | $173.99 | 2025 | |
| Life Spine, INC. | $150.00 | 2023 | Prolift |
| Stryker Corporation | $148.31 | 2021-2024 | Inspace, Iconix |
| Zimmer Biomet Holdings, INC. | $130.18 | 2020 | |
| Allergan, INC. | $125.00 | 2020 | |
| Gilead Sciences, INC. | $54.43 | 2022 | |
| Ethicon US, LLC | $34.72 | 2025 | Vistaseal |
| Heron Therapeutics, INC. | $34.34 | 2024 | Zynrelef |
| Innovation Technologies INC | $20.11 | 2024 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $18.76 | 2022 | |
| Boston Scientific Corporation | $14.24 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $12.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ramsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.